Pre-admission prescription of selective serotonin reuptake inhibitors and mortality in critical illness: a national cohort study from 2020 to 2023
Tak Kyu Oh, In-Ae Song · 2026
Read Pre-admission prescription of selective serotonin reuptake inhibitors and mortality in critical illness: a national cohort study from 2020 to 2023 by Tak Kyu Oh, In-Ae Song (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13634290.txt.
Description
Tak Kyu Oh and In-Ae Song ask whether a common type of antidepressant, taken just before intensive care, links to survival. Their 2026 study uses health records for adults across South Korea from 2020 through 2023. The drugs are called selective serotonin reuptake inhibitors, or SSRIs. The team counted prescriptions filled in the 30 days before a first stay in intensive care.
Patients with a recent prescription died less often within 30 and 90 days. The gap held after the team matched patients on other traits. It looked stronger in patients with recorded mental health disorders. The authors stress that linked records cannot prove the drugs caused the gap. Other hidden traits may explain part of it.
Catalog record
| CREATOR | Tak Kyu Oh, In-Ae Song |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |